GV

GV Management Company, LLC, formerly known as Google Ventures, serves as the venture capital arm of Alphabet Inc., established in 2009 and headquartered in Mountain View, California, with additional offices in Boston, New York, Cambridge, and London. The firm specializes in growth capital investments across various stages, including seed, early, mid, and late stages, focusing on sectors such as life sciences, healthcare, artificial intelligence, robotics, cyber security, and agriculture. GV has invested in over 300 companies, seeking to support startups that aim to innovate and transform industries. The firm typically invests up to $50 million, with smaller amounts allocated to early-stage ventures. GV provides its portfolio companies with exceptional support by connecting them with Google's resources and talent, leveraging a team of experts in engineering, design, science, and marketing to enhance their growth potential.

Karthik Ardhanareeswaran

Principal

Brian Bendett

Partner

Scott Biller

Venture Partner

Brendan Bulik-Sullivan

General Partner

A Marty Cannon

Founder and Managing Member

Sherry Chao

Principal

Tyson Clark

General Partner

Frederique Dame

Partner

Scott Davis

Venture Partner

Karim Faris

General Partner

Catherine J. Friedman

Executive Venture Partner

Cathy Friedman

Venture Partner

Anika Gupta

Principal

Han Hua

Principal

Crystal Huang

Partner

Tom Hulme

General Partner and Head of Europe

Rosana Kapeller

Investor

John Lyman

Partner

Michael Margolis

Partner

Laura Melahn

Partner

Dave Munichiello

Managing Partner

Erik Nordlander

General Partner

Sridhar Ramaswamy

Venture Partner

Leena Rao

Content Partner

David Reshef

Venture Partner

Ben Robbins

General Partner

Issi Rozen

Venture Partner

Elena Sakach

Investment Partner

Luna Schmid

Partner

Vidu Shanmugarajah

Partner

M.G. Siegler

General Partner

Graham Spencer

Managing Partner

Jon Stritar

Partner

Andy Wheeler

General Partner

Jeremy Whelchel

Partner

Sangeen Zeb

General Partner

Past deals in USA

Comanche Biopharma

Venture Round in 2023
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.

AMP

Series C in 2023
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Cerevance

Series B in 2023
Cerevance LLC is engaged in the development of therapeutics targeting specific proteins expressed selectively in brain cell types affected by neurological diseases. The company utilizes its proprietary NETSseq platform to profile distinct brain cell types, such as neurons and glial cells, in mature human brain tissue. This technology reveals transcriptional and epigenetic differences, facilitating the early detection and treatment of serious neurological and psychiatric disorders, including Alzheimer’s and Parkinson’s diseases. Founded in 2016, Cerevance is headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom. The company's focus is on advancing new medicines for central nervous system diseases by addressing the underlying mechanisms of neurodegeneration and related conditions.

Jetpack

Seed Round in 2023
Jetpack creates scalable cloud backend software for engineers to help them with coding and cloud services. The platform develops software that builds scalable web backends for the cloud and creates images and configurations directly from annotated python code.

Galileo

Series D in 2022
Galileo, Inc. is a technology company that specializes in developing healthcare mobile applications designed to facilitate medical care and expertise. Founded in 2014 and headquartered in Washington, D.C., the company provides an online communication platform that allows healthcare providers and patients to connect through synchronous and asynchronous telecommunications technologies. By leveraging these innovative solutions, Galileo aims to enhance access to comprehensive clinical care directly from mobile devices, improving the overall patient experience in healthcare delivery.

Flatfile

Series B in 2022
Flatfile Inc. offers a platform designed to streamline the data onboarding process for businesses by allowing developers to validate, map, and import data from various web applications. Founded in 2018 and based in Denver, Colorado, the company's key products include Portal, an import button that integrates seamlessly into software applications through a JavaScript snippet, and Concierge, which provides secure workspaces for collaboration on data ingestion challenges. Flatfile's platform supports multiple file formats, including CSV, XLS, and TSV, and features a JavaScript configurator that enables users to define target models for data validation. This automation helps organizations manage and structure imported data effectively, reducing the time spent on data cleaning and allowing teams to focus on utilizing their data for decision-making.

Sardine

Series B in 2022
FinTech, RegTech, Fraud Operating System

Pretzel Therapeutics

Series A in 2022
Pretzel Therapeutics is a biotechnology company focused on developing therapies for mitochondrial dysfunction. Founded by leading experts in mitochondrial biology, the company aims to create innovative treatments that address the underlying causes of mitochondrial issues. By leveraging a comprehensive understanding of mitochondrial mechanisms, Pretzel Therapeutics seeks to reverse dysfunction at its roots, potentially providing effective solutions for patients suffering from a range of conditions, including those related to aging. The company's name reflects its scientific focus on the mitochondrion, which is characterized by its unique and highly folded inner membrane, distinguishing it from other organelles in the body.

Omni

Series A in 2022
Omni is the only BI platform that combines the consistency of a shared data model with the freedom of SQL. Omni was founded in 2022 and was headquartered in California, United States.

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Vicinitas Therapeutics

Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Xilis

Series A in 2022
Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

Merlin Labs

Series B in 2022
Merlin Labs is building an autonomous infrastructure for the sky above us, enabling goods, and eventually people, to fly without pilots.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

MemSQL

Series F in 2022
SingleStore, Inc. is a provider of relational databases designed for both cloud and on-premises transactions and analytics. The company offers the SingleStore Managed Service, a cloud database-as-a-service that facilitates analytics on various cloud platforms, as well as SingleStore DB, a distributed SQL database suitable for operational analytics on bare metal and hybrid cloud environments. SingleStore's solutions include modernizing data platforms, securing government workloads, IoT analytics, and customer interaction management, serving diverse sectors such as financial services, media, energy, government, and retail. Founded in 2011 and headquartered in San Francisco, California, SingleStore also has offices in Seattle, Boston, Portland, Lisbon, and London. Previously known as MemSQL Inc., the company rebranded to SingleStore, Inc. in October 2020.

FYTO

Series A in 2022
FYTO provides innovative solutions which improve the economic and environmental sustainability of agriculture for farmers around the world. FYTO is developing: NOVEL NUTRIENT-DENSE CROPS that have ultra-high yields and ultra-low resource requirements, STATE-OF-THE ART CULTIVATION AND HARVESTING SYSTEMS for exceptional quality and consistency, CLIMATE-FRIENDLY METHODOLOGIES for resiliency and long-term sustainability, and a range of GROUNDBREAKING AGRICULTURAL PRODUCTS such as animal feed and biofertilizer.

Modular

Seed Round in 2022
Modular is an AI software development platform aimed at simplifying the creation and deployment of artificial intelligence applications. The platform integrates various popular frameworks through common interfaces, enhancing usability and flexibility while ensuring compatibility across diverse hardware backends and cloud environments. This approach allows developers to adopt the tools seamlessly into their existing workflows without the need for extensive code modifications. By focusing on production-quality infrastructure and a straightforward user experience, Modular enables developers to save time and increase their productivity, ultimately streamlining the development process from edge to datacenter.

Courier

Series B in 2022
Courier provides an API that enables developers to manage and route user notifications across various communication channels, such as email and messaging platforms. By leveraging user engagement data and online status, the API optimizes notification delivery, ensuring that messages reach users through the most effective medium. The company's notification management software allows clients to create reusable messages that can be customized for different channels, facilitating timely and targeted communication. Over the years, Courier has adapted to technological advancements while maintaining a stable management approach, emphasizing the importance of customer success. The company has developed long-lasting relationships with its largest clients, continually collaborating to meet their evolving needs.

Sanas

Series A in 2022
Sanas is a technology company that specializes in real-time accent translation services. Its innovative software enables users to communicate effectively by allowing them to speak in any accent of their choice without noticeable lag. By addressing language barriers and accent mismatches, Sanas enhances understanding and facilitates smoother interactions. The technology is designed to be locally installed on users' devices, giving them full control over when and how to utilize the accent-matching features. This approach not only empowers users to communicate more freely but also promotes inclusivity in conversations across diverse linguistic backgrounds.

Ahana

Series A in 2022
Ahana, founded in 2020 and located in San Mateo, California, specializes in PrestoDB-based ad hoc analytics solutions. As the first company to focus on bringing these offerings to market, Ahana aims to simplify ad hoc analytics for organizations of various sizes. The company's mission includes fostering growth and supporting the Presto community, which is already in extensive use by major internet companies. Ahana operates as a fully remote organization, reflecting its commitment to flexibility and modern workplace practices.

Sesame

Series B in 2022
Sesame, Inc., operating as SesameCare, is a company that offers a platform for booking doctor appointments and accessing medical care. Founded in 2018 and based in New York, SesameCare aims to simplify the healthcare experience by connecting patients directly with doctors, providing upfront pricing and clear descriptions of medical services. This approach is particularly beneficial for uninsured individuals or those opting to pay out-of-pocket, as it addresses common issues such as hidden costs and unexpected charges that often complicate healthcare access. By focusing on transparency and affordability, SesameCare endeavors to make quality healthcare more accessible for all patients.

Nava

Series B in 2022
Nava is a New York-based company that specializes in health insurance brokerage services aimed at delivering high-quality, affordable healthcare solutions to employers and their employees. The firm provides a range of healthcare tools, year-round employee advocacy, and continuous measurement to assess and recommend healthcare plans. By focusing on these aspects, Nava helps clients manage their employee benefits effectively while reducing overall plan costs. This approach allows businesses to offer the necessary benefits to their workforce, ensuring both accessibility and affordability in healthcare coverage.

Strella

Series A in 2022
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

FarmWise

Series B in 2022
FarmWise Labs, Inc. develops innovative robotic machinery aimed at enhancing agricultural efficiency. Founded in 2016 and based in San Francisco, the company specializes in autonomous cultivation solutions, particularly focusing on weeding and thinning crops. FarmWise's technology utilizes machine learning and artificial intelligence to perform essential farming tasks such as weeding, planting, sowing, and soil tilling. Their autonomous vegetable weeder is designed to minimize the use of herbicides, allowing farmers to cultivate healthier crops while improving overall productivity. By streamlining farm operations, FarmWise aims to support sustainable farming practices and increase food production efficiency.

Gametime

Venture Round in 2022
Gametime United, Inc. develops a mobile application to book tickets. The company’s application enables users to buy and sell tickets for NBA, NHL, MLB, MLS, NCAA, and NFL teams. It offers its application for iOS and Android platforms through App Store and the Google Play Store. The company was founded in 2012 and is based in San Francisco, California.

Mirvie

Series B in 2022
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, that specializes in developing protein-based therapeutics for animal health care. The company focuses on creating biopharmaceutical solutions that apply human biotechnology advancements to veterinary medicine. Invetx aims to build a premier innovation platform for veterinary therapeutics, collaborating with leading biotechnology firms, investors, and industry experts. Its team, which includes veterinary scientists and clinicians, is dedicated to discovering and developing a diverse portfolio of therapies and technologies. The company's vision is to enhance health outcomes for both pets and farm animals by leveraging biopharma technologies in the global animal health industry.

Graft

Pre Seed Round in 2022
Graft is a cloud-native platform that uses AI techniques to unlock the value of text, images, video, audio, and graphs. There is no requirement for machine learning skills, no need to hire a team, and no infrastructure to build or maintain.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience, Inc. is a biotechnology company based in San Diego, California, focused on developing induced pluripotent stem cell therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018, the company aims to create patient-specific restorative cell therapies that can alter the progression of the disease. Its product pipeline includes ANPD001, an autologous neuron replacement therapy designed for sporadic Parkinson's disease, and ANPD002, a gene-edited version targeting familial forms of the disease. By integrating innovative genomic approaches with stem cell biology, Aspen Neuroscience seeks to advance the field of personalized medicine and improve treatment outcomes for patients suffering from Parkinson's disease.

Veza

Venture Round in 2022
Cookie.AI is a stealth-mode startup based in the Silicon Valley / Bay Area. We are building SaaS based security products in a dynamic and fast moving world of cybersecurity with ideas rooted in the era of privacy for the cloud. We are well-funded and backed by top-tier VCs and CEOs as angel investors. The founders are serial entrepreneurs who have experience in the full 0-to-1 journey with a successful exit with an acquisition. We are looking for founding engineers (summer interns also welcome!) with strong interests in security / cloud-native systems / identity / SaaS.

Waltz Health

Series A in 2022
Waltz Health operates in the pharmaceutical supply chain, focusing on creating innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company develops consumer tools aimed at guiding decisions related to prescription care, with a particular emphasis on the needs of both payers and consumers. By utilizing AI-driven marketplaces, Waltz Health seeks to reduce costs and enhance the decision-making process for users. Their offerings provide better pricing information and resources that empower consumers while assisting payers in managing their pharmacy benefits more effectively.

Viz

Series D in 2022
Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.

Stackblitz

Seed Round in 2022
StackBlitz is a developer of software that provides essential tools for computer programmers engaged in software development. Its platform includes a source code editor, build automation tools, and a debugger, facilitating the creation and sharing of live projects. This allows users to initiate Angular or React projects without the complexity of installing dependencies. Additionally, StackBlitz supports offline editing and real-time application tweaking, enabling developers to maintain application state without requiring page refreshes. The company's offerings enhance the efficiency of web development, making it easier for programmers to focus on their projects.

Rattle

Series A in 2022
Rattle is a technology company that offers a Salesforce integration solution aimed at enhancing the efficiency of sales and customer experience teams. By allowing users to access and manage Salesforce directly through Slack, Rattle addresses common challenges related to Salesforce adoption. This integration enables sales representatives to log calls, track essential metrics, and update opportunities seamlessly, facilitating real-time visibility into customer relationship management. The platform has proven effective for industry leaders, saving sales representatives an average of 30 minutes per day in pipeline management and reducing data hygiene issues by up to 50%. Rattle's solution ultimately allows marketing professionals to focus more on customer engagement rather than internal processes.

Obsidian Security

Series C in 2022
Obsidian Security, Inc. is a technology company based in Newport Beach, California, specializing in cybersecurity solutions tailored for hybrid-cloud environments. Founded in 2017 by former members of renowned companies in the security sector, Obsidian Security focuses on leveraging artificial intelligence to address cyber threats. Its platform provides comprehensive services, including threat detection, breach remediation, and security hardening specifically for software as a service (SaaS) applications. The company's offerings aim to deliver intelligent identity protection and seamless security, enabling enterprises to safeguard their interconnected systems without hindering productivity. Backed by notable investors, Obsidian Security positions itself at the forefront of the evolving cybersecurity landscape.

Brightline

Series C in 2022
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families.

Digits

Series C in 2022
Digits Financial, Inc. is a fintech company founded in 2018 and based in San Francisco, California. The company specializes in developing software that offers a real-time view of a business's finances. Its platform streamlines the creation of financial reports and transaction records, significantly reducing manual workload. By visualizing and managing financial data, Digits enhances interactions between businesses and their accountants, investors, and advisors. This innovative approach positions Digits as a key player in providing modern financial solutions for businesses.

Celsius Therapeutics

Series B in 2022
Celsius Therapeutics is a biotechnology company focused on developing innovative medicines to treat complex diseases, including autoimmunity and cancer. Founded in 2017 and based in Cambridge, Massachusetts, the company leverages advanced techniques such as single-cell genomic analysis and machine learning to gain insights into the cellular ecosystems of diseases. By systematically applying single-cell sequencing and analyzing extensive datasets with sophisticated algorithms, Celsius Therapeutics aims to discover critical biomarkers and precision therapies that enhance patient care and enable clinicians to identify genes that play a causal role in various conditions.

LifeMine

Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated, genomically-enabled drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine aims to elucidate human biology and develop innovative therapeutics that target the underlying causes of serious diseases. By mining fungal biodiversity, the company seeks to create novel therapeutics designed to tackle previously intractable medical challenges, ultimately enhancing treatment options for healthcare providers.

Spotlight Therapeutics

Series B in 2022
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.

Agolo

Series A in 2022
Agolo, Inc. is a technology company that specializes in developing an artificial intelligence platform designed to create real-time summaries from unstructured data. Founded in 2012 and based in New York, Agolo employs machine learning and natural language processing to analyze vast amounts of information, enabling users to quickly grasp key points relevant to their interests. The platform enhances the efficiency of analysts by summarizing thousands of documents and identifying connections between subjects, thereby facilitating better decision-making in fields such as finance and intelligence. By streamlining the information processing workflow, Agolo allows professionals to focus on strategic actions rather than data interpretation.

DNAnexus

Series H in 2022
DNAnexus, Inc. specializes in cloud-based genome informatics and data management tools tailored for enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company provides a platform that facilitates the analysis of raw sequencing data, integrates genomic data with clinical information, and enhances collaboration among researchers. Key offerings include the MOSAIC Microbiome platform for microbiome research, DNAnexus Apollo for clinico-genomic data exploration, DNAnexus Titan for data analysis, and DNAnexus Portals, which create secure online workspaces for collaborative projects. Additionally, the Clinico-Genomic Data Solution aims to enhance disease-specific datasets through partnerships with healthcare providers, improving screening and treatment pathways for complex diseases. DNAnexus serves a diverse clientele, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

DBT

Series D in 2022
dbt Labs, founded in 2016 and based in Philadelphia, operates a software-as-a-service platform that specializes in open-source data engineering. The company's primary offering, the data build tool (dbt), empowers data analysts and engineers to organize, cleanse, and transform data for analysis using SQL. This platform facilitates data modeling, event tracking, and KPI measurement, enabling users to build efficient data transformation workflows. In addition to its core software, dbt Labs provides training and consulting services in data analytics, supporting organizations in leveraging their data more effectively. Through its mission to enhance the creation and dissemination of organizational knowledge, dbt Labs positions itself as a vital resource for businesses seeking to improve their data analytics capabilities.

Redpanda

Series B in 2022
Redpanda is a queue for people who deal with massive data streams.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Helium

Series D in 2022
Helium Systems Inc. specializes in Internet of Things (IoT) solutions, focusing on the development of smart sensor devices for various industries. These sensors monitor critical environmental factors such as temperature, humidity, barometric pressure, motion, and light, aiding in facility management and quality control for medical products, energy efficiency, air quality, and refrigeration. The company offers a web and mobile dashboard that allows users to manage and access their sensor data easily. Additionally, Helium operates a peer-to-peer wireless network designed to enhance connectivity for low-power IoT devices. This network incentivizes individuals to act as network operators by rewarding them with cryptocurrency for verifying transactions and maintaining coverage through a unique algorithm called Proof-of-Coverage. Incorporated in 2013 and based in San Francisco, Helium continues to innovate in the IoT space, providing robust solutions for data transfer and network connectivity.

Overview

Series A in 2022
Overview Corporation specializes in developing advanced computer vision systems and smart cameras aimed at enhancing operational efficiency in wire and cable manufacturing. The company's technology focuses on real-time error detection and equipment monitoring, utilizing artificial intelligence to learn normal machine routines and identify deviations, crashes, and anomalies. Its inspection and monitoring systems are designed to prevent significant damage to products or machinery by catching issues such as misalignments and breakages early in the manufacturing process. Additionally, Overview Corporation's platform offers built-in analytics for remote factory tracking and provides users with live video feeds, event detection, and custom alerts, ensuring comprehensive operational visibility. Founded in 2018 and headquartered in San Francisco, California, the company serves the manufacturing sector across the United States.

Voltron Data

Series A in 2022
Developer of an open-source platform designed to build bridges across the data analytics ecosystem. The company's platform connects data, hardware, and developers and builds multi-language across platform tools for accelerated data interchange and in-memory processing, enabling developers, data scientists, and data engineers to improve the toolchains and interoperability standards for data access, preparation, cleaning, analytics, and feature engineering.

Voltron Data

Seed Round in 2022
Developer of an open-source platform designed to build bridges across the data analytics ecosystem. The company's platform connects data, hardware, and developers and builds multi-language across platform tools for accelerated data interchange and in-memory processing, enabling developers, data scientists, and data engineers to improve the toolchains and interoperability standards for data access, preparation, cleaning, analytics, and feature engineering.

Homebound

Series C in 2022
Homebound Inc. is a technology-driven custom home builder based in Santa Rosa, California, founded in 2017. The company specializes in constructing residential homes and offers a comprehensive range of support services, including architecture, design, financing, and insurance consultancy. Originating in response to the 2017 Northern California wildfires, Homebound aims to simplify the homebuilding process by providing a transparent and streamlined experience for homeowners. It manages the entire building journey, assisting clients from insurance negotiation and architectural design to permitting and construction. By leveraging user-friendly technology and a network of qualified building professionals, Homebound addresses the complexities and uncertainties homeowners face, particularly in the aftermath of natural disasters, enabling them to rebuild their homes more efficiently.

Neo.Tax

Series A in 2022
Neo.tax is a tax preparation and filing service based in Mountain View, California, that specializes in assisting early-stage startups. The company offers a tax automation platform that employs machine learning algorithms to streamline the collection and organization of data from various sources, including emails, documents, project management tools, and financial systems. This technology generates comprehensive reports that detail all activities, expenses, and methodologies used to claim tax credits. By enhancing accuracy and simplifying the review process, Neo.tax aims to ensure that businesses are audit-ready, thereby facilitating a more efficient and reliable tax filing experience.

Scandit

Series D in 2022
Scandit AG, established in 2009 and headquartered in Zurich, Switzerland, specializes in mobile computer vision and augmented reality solutions, focusing on barcode scanning software. Its offerings include the Scandit Keyboard Wedge, which enables enterprise-grade barcode scanning on mobile devices, and the Barcode Scanner SDK, which allows for barcode scanning integration in web applications. The MatrixScan technology enhances the speed of barcode and text recognition, making it valuable for industries such as retail, logistics, manufacturing, healthcare, and government. Scandit's solutions are designed to improve operational efficiency by enabling mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating patient and medication tracking in healthcare settings. The company serves a diverse clientele, including well-known organizations like 7-Eleven, Carrefour, and Toyota, among others, and has additional offices in San Francisco, Boston, London, and Warsaw.

Seismic Therapeutic

Series A in 2022
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its IMPACT™ platform, Seismic Therapeutic aims to tackle key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This comprehensive approach facilitates the creation of optimized therapies that can reach patients more quickly. The company is developing a pipeline of innovative biologics targeting adaptive immune system dysregulation, with the goal of treating autoimmune diseases.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics U.S., Inc. is a biopharmaceutical company based in Natick, Massachusetts, with an additional location in Montreal, Canada. Founded in 2019, it focuses on discovering and developing novel small-molecule medicines that target the innate immune system to address autoimmune diseases, inflammatory diseases, and cancer. The company employs a structural immunology platform that integrates protein engineering to elucidate molecular structures and mechanisms of action. This platform facilitates the development of precise binding and functional screening assays, as well as structure-based modeling. Ventus Therapeutics is advancing an emerging pipeline of drug programs aimed at key targets within the innate immune system, leveraging its proprietary capabilities in rational and structure-based drug design.

Synapticure

Seed Round in 2022
Synapticure is a tele neurology startup focused on providing customized care for patients with Amyotrophic Lateral Sclerosis (ALS) and their families. The company operates a virtual clinical care platform that leverages advances in science and technology to identify and treat each patient's specific needs. Through this platform, patients gain easy access to neurologists and comprehensive behavioral health services, including psychiatry and therapy care coordination, all integrated into one system. This approach aims to enhance the patient experience by ensuring that they receive the necessary support and resources while managing their condition from the comfort of their homes.

Lacework

Venture Round in 2022
Lacework, Inc. is a provider of a cloud security platform that ensures comprehensive security and compliance across various cloud environments, including AWS, Azure, GCP, and private clouds. Founded in 2014 and based in Mountain View, California, the company offers its flagship solution, Polygraph, which secures customer accounts, workloads, and data while detecting anomalies and delivering actionable insights for incident remediation. Lacework's platform automates critical security functions such as configuration assessment, behavior monitoring, threat detection, and incident investigation, offering continuous monitoring of all cloud components, including workloads, applications, and containers. This unified approach enables organizations to innovate rapidly while maintaining a secure and compliant cloud infrastructure.

Censys

Series B in 2022
Censys, Inc. is a cybersecurity company specializing in internet scanning and asset identification solutions. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides an internet device search engine that allows users to discover and analyze devices connected to the Internet, including computers, servers, and smart devices. The platform is utilized for various applications such as attack surface management, monitoring remote workforces, and identifying potential threats. Censys is recognized for delivering real-time visibility and risk assessments, making it a valuable resource for researchers, corporations, and government entities. The company's data-driven security solutions are employed by notable organizations, including FireEye, Google, NATO, and the U.S. Department of Homeland Security, to enhance their cybersecurity measures and proactively address threats.

TenSixteen Bio

Series A in 2022
TenSixteen Bio is a biotechnology company based in San Francisco that specializes in developing innovative therapeutics for various age-related disorders. The company focuses on leveraging somatic mosaicism and clonal hematopoiesis in its approach to precision medicine, aiming to address complex diseases such as cancer and cardiovascular conditions. By utilizing advanced DNA analysis, TenSixteen Bio seeks to discover and develop new treatments that can enhance the capabilities of pharmaceutical companies in managing these diseases. Co-founded by Foresite Labs, TenSixteen Bio is dedicated to transforming the future of healthcare through its unique therapeutic strategies.

Agtonomy

Seed Round in 2022
Agtonomy is a hybrid autonomy and tele-assist platform for agriculture vehicles.

Verana Health

Series E in 2022
Verana Health, Inc. is a software company dedicated to improving the connection between healthcare providers and mobile diagnostics. Based in San Francisco, the company provides a range of tools designed to facilitate real-time access to diagnostic data for both patients and physicians. Its flagship product, SightBook, is a mobile application that allows users to assess their vision and share results with their healthcare providers instantly, while also enabling physicians to manage appointments and treatments effectively. In addition to SightBook, Verana Health offers a cloud-based portal, a smartphone application for vision assessments, mobile imaging devices, and analytics tools that support the monitoring of patient data. By partnering with leading medical associations, Verana Health transforms clinical data into actionable insights, helping to accelerate medical research and improve patient care. The company was previously known as Digisight Technologies, Inc. before rebranding in July 2018 and has been operational since its incorporation in 2008.

Dialpad

Series F in 2021
Dialpad, Inc. is a cloud-based platform based in San Francisco, California, that specializes in enterprise communications. The company offers a comprehensive suite of services including voice, video, group messaging, SMS, MMS, conferencing, and document sharing, all powered by advanced AI technologies. Its products, such as Dialpad, Dialpad Sell, UberConference, and Dialpad Contact Center, are designed to enhance collaboration and streamline communication for teams working remotely. Notably, Dialpad provides features like real-time transcription, automated note-taking, live sentiment analysis, and voice analytics, which help organizations optimize their interactions and improve decision-making. The company was founded in 2011 and has established a diverse customer base that includes notable names like Motorola Solutions and Warby Parker. Dialpad has also formed strategic alliances with major investors, including SoftBank Corp. and Salesforce Ventures, to further its mission in transforming enterprise communication.

Cockroach Labs

Series F in 2021
Cockroach Labs, Inc. specializes in developing open-source database software, notably CockroachDB, which is a distributed SQL database tailored for modern cloud applications. Founded in 2015 and headquartered in New York, the company also has an office in Cambridge, Massachusetts. CockroachDB is designed to scale horizontally and can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, while maintaining minimal latency and no need for manual intervention. It supports strongly-consistent ACID transactions and offers an SQL API for data management. The software is suitable for diverse clients, ranging from startups to Fortune 500 companies, and is utilized for enterprise-grade disaster recovery services. CockroachDB combines the rich features of SQL with the scalability typically associated with NoSQL databases, enabling developers to innovate rapidly without compromising on consistency. The platform is trusted by major enterprises across various sectors, including finance, retail, and media.

Wonder

Series A in 2021
Wonder is a gaming company focused on creating an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across various devices, thereby enhancing the overall gaming experience. In addition to its software solutions, Wonder is also involved in developing VR-ready gaming hardware. Currently, the company operates in stealth mode, suggesting that it is in the early stages of development and may be working on innovative features or products.

Universe

Series B in 2021
Universe is a mobile-based website builder established in 2014 and headquartered in Brooklyn, New York. The platform aims to empower users to create customized websites quickly and easily, catering to the needs of small business owners and individuals who prefer mobile solutions. By offering a unique approach that eliminates complicated templates, Universe utilizes customizable website filters that allow users to arrange photos, videos, and icons on a grid pattern through a simple drag-and-drop interface. This enables users to build mobile-optimized websites in just minutes using the company's iOS app, providing them with full control over their online presence.

Quartet Health

Corporate Round in 2021
Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the company partners with health plans and health systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. Quartet's platform facilitates access to suitable mental health care tailored to individual preferences and clinical needs, ensuring that care is compatible with patients' insurance plans. By connecting physicians, mental health providers, and insurance companies, Quartet seeks to improve the overall health of patients while also reducing healthcare costs.

Groundswell

Seed Round in 2021
Groundswell provides a SaaS platform for philanthropic giving, which enables companies to fund personal donor-advised funds for each employee. Employee users are also provided with tools such as tax-free investment opportunities, customized giving opportunities, frictionless donation options, and centralized impact reporting.

Upbound

Series B in 2021
Upbound, Inc. is a technology company based in Seattle, Washington, that specializes in providing a multi-cloud platform which allows organizations to manage and optimize services across various public and private cloud environments. Founded in 2017, Upbound offers solutions that enable automation, cost optimization, and policy enforcement, facilitating scalable deployments and application management. Its platform empowers organizations to treat multiple disparate cloud environments as a single cohesive unit, enhancing efficiency and reducing operational costs while ensuring portability and failover capabilities.

Vercel

Series D in 2021
Vercel Inc. is a cloud platform that specializes in on-demand deployment, hosting, and sharing services for frontend applications. Founded in 2015 and based in Walnut, California, the company provides automated deployment solutions integrated with GitHub, Bitbucket, and GitLab, allowing projects to be deployed seamlessly from pull requests and merge requests. Vercel's platform is designed to enhance the development and deployment experience for frontend teams by hosting static websites and serverless functions that align with the Jamstack deployment model. This model ensures that web pages are pre-rendered and can be efficiently served by a content delivery network, delivering optimal performance for developers. Vercel was formerly known as ZEIT, Inc. before rebranding in April 2020.

Farmer Business Network

Series G in 2021
Farmer Business Network (FBN) is an independent agronomic information network designed to enhance the livelihoods of farmers by making data accessible and useful. Leveraging data science and machine learning, FBN offers its members unbiased insights about their fields, drawing on billions of data points collected from a vast network of farmers. The platform provides valuable resources such as product performance analytics, benchmarking, and predictive insights based on real-world agricultural data. By connecting farmers across the United States, FBN helps them achieve input savings, gain profitable insights, and secure better crop prices, ultimately fostering a collaborative environment that benefits the agricultural community.

mabl

Series C in 2021
Mabl Inc. offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. Founded in 2016 and based in Boston, Massachusetts, the company provides a scriptless testing solution as part of its software-as-a-service (SaaS) offerings. Mabl facilitates machine-driven regression testing and integrates seamlessly into the continuous integration and continuous delivery (CI/CD) development lifecycle. Its platform allows software development teams to create, execute, and maintain auto-healing tests efficiently, ensuring the rapid delivery of high-quality applications. Mabl serves a range of enterprise clients, including Johnson Controls, Liberty Mutual, Molina Healthcare, JetBlue, Dollar Shave Club, and Charles Schwab, who rely on its services for testing their critical applications.

Ankyra

Series B in 2021
Provider of cancer therapy services intended to improve both the safety and efficacy of cytokine immunotherapies for cancer patients. The company's services offer systemic dosing of these immune stimulants that have historically been limited by broad immune activation and toxicity, develops cancer therapies based on tumor-localized immune potentiating agents that boost anti-tumor immune responses, enabling patients to find an instant treatment for cancer without any surgery.

Signos

Series A in 2021
Developer of weight loss application designed to recommend meals and exercises that transform the weight loss journey. The company's software along with a wearable device provides glucose monitoring and visualizes metabolism in real time, enabling users to track their glucose count and keep their diet under control.

Yellowbrick Data

Series C in 2021
Yellowbrick Data, Inc. is a technology company founded in 2014 and headquartered in Palo Alto, California, with additional offices in Salt Lake City, Hong Kong, and London. The company specializes in developing and deploying data warehouse solutions, offering both on-premises and cloud-based options. Its platform is designed to efficiently store, transform, and analyze large volumes of business data, enabling organizations to run complex mixed workloads and support numerous concurrent users. Yellowbrick’s data warehouse allows for seamless analytics across various environments, including private and public clouds, while delivering superior performance and cost-effectiveness. By addressing challenges such as high availability and scalability, Yellowbrick Data empowers enterprises to make faster, data-driven decisions.

Antiva Biosciences

Series D in 2021
Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego. They are now Antiva Biosciences which is headquartered in South San Francisco.

Patina

Series A in 2021
We believe everyone should have the opportunity to live their best lives and age with dignity. That’s why we’re reinventing primary care with an approach designed to profoundly improve the healthcare and aging experience for older adults and their loved ones.

Modern Age

Series A in 2021
Modern Age is a health and wellness platform focused on improving the aging process for individuals. It offers health monitoring software that employs computer vision and machine learning to assess skin, hair, and bone health. The platform also integrates data collected from smart bands to create a comprehensive digital record of an individual's well-being. By analyzing this information, Modern Age provides personalized insights and treatment recommendations, empowering users to manage their health more effectively and lead healthier lives as they age.

Flock Freight

Series D in 2021
Flock Freight Inc. specializes in less-than-truckload (LTL) freight shipping and management services across North America. The company uses innovative algorithms to pool LTL and partial-truckload shipments into full truckloads, enhancing efficiency and reducing costs for businesses. Its flagship product, FlockDirect, enables seamless transportation of pooled freight without the need for terminals, ensuring safe and direct deliveries. Additionally, Flock Freight offers a technology platform that consolidates multiple shipments into multi-stop routes, optimizing logistics for shippers and maximizing revenue opportunities for carriers. Founded in 2015 and headquartered in Solana Beach, California, Flock Freight aims to transform the LTL freight industry through advanced technology and a focus on customer experience.

RightHand Robotics

Venture Round in 2021
RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.

Matter

Series A in 2021
Matter is a social reading application based in the United States that focuses on articles, blogs, and newsletters. The platform aims to enhance users' reading experiences by curating and presenting high-quality content, helping them discover better material online. Through its user-friendly interface, Matter facilitates engagement with a diverse range of written works, making it easier for individuals to connect with relevant information and insights.

IonQ

Post in 2021
IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.

Agtonomy

Seed Round in 2021
Agtonomy is a hybrid autonomy and tele-assist platform for agriculture vehicles.

Ripple Foods

Series E in 2021
Ripple Foods specializes in producing high-quality, dairy-free milk alternatives that prioritize nutrition and taste. Their products are designed to be high in protein, offering eight times the protein found in almond milk while containing half the sugar of traditional dairy milk. Additionally, Ripple's beverages are rich in bioavailable calcium, providing 50% more than regular milk, and are a good source of potassium and omega-3 fatty acids. With a focus on delivering a creamy texture that enhances the drinking experience, Ripple aims to provide a satisfying alternative for those seeking non-dairy options without sacrificing flavor or nutritional value.

Ripple Foods

Series E in 2021
Ripple Foods specializes in producing high-quality, dairy-free milk alternatives that prioritize nutrition and taste. Their products are designed to be high in protein, offering eight times the protein found in almond milk while containing half the sugar of traditional dairy milk. Additionally, Ripple's beverages are rich in bioavailable calcium, providing 50% more than regular milk, and are a good source of potassium and omega-3 fatty acids. With a focus on delivering a creamy texture that enhances the drinking experience, Ripple aims to provide a satisfying alternative for those seeking non-dairy options without sacrificing flavor or nutritional value.

Altana

Series A in 2021
Altana AI specializes in developing artificial intelligence software solutions for supply chain management, aimed at enhancing visibility and risk management in global trade. Founded in 2018 and based in New York, the company leverages extensive economic data to create a shared AI platform that facilitates better decision-making for governments, businesses, financial institutions, and logistics providers. Its flagship product, The Altana Trade Knowledge Graph, provides a real-time overview of transactions, ownership, movements, cyber activities, and associated risks within the global trade network. By integrating various data sources and utilizing machine learning, Altana AI seeks to make trade safer, more efficient, and more profitable for its clients.

StrongDM

Series B in 2021
strongDM manages and audits access to servers and databases. It provides a single platform to control access to any database for employees, vendors, and cloud-based tools. The company was awarded in the Strata+Hadoop World Audience Favorite in 2016. It was incorporated in 2015 and is headquartered in Burlingame, California.

ROME Therapeutics

Series B in 2021
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, ROME Therapeutics is pioneering the exploration of the repeatome, which consists of extensive regions of genetic material previously considered "junk DNA." The company has identified several drug targets and is actively advancing multiple discovery programs. To facilitate its research, ROME has assembled a team of experts across various disciplines, including oncology, immunology, virology, and machine learning, to harness this uncharted area of biology for therapeutic advancements.

MemSQL

Series F in 2021
SingleStore, Inc. is a provider of relational databases designed for both cloud and on-premises transactions and analytics. The company offers the SingleStore Managed Service, a cloud database-as-a-service that facilitates analytics on various cloud platforms, as well as SingleStore DB, a distributed SQL database suitable for operational analytics on bare metal and hybrid cloud environments. SingleStore's solutions include modernizing data platforms, securing government workloads, IoT analytics, and customer interaction management, serving diverse sectors such as financial services, media, energy, government, and retail. Founded in 2011 and headquartered in San Francisco, California, SingleStore also has offices in Seattle, Boston, Portland, Lisbon, and London. Previously known as MemSQL Inc., the company rebranded to SingleStore, Inc. in October 2020.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Snorkel

Series C in 2021
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform aimed at facilitating the creation, management, and monitoring of AI applications. Central to its offerings is Snorkel Flow, a data-first platform that enables users to programmatically label and augment training data, manage data for AI purposes, and deploy various machine learning models. The platform is particularly effective in extracting entities and structured information from complex documents, making it valuable across multiple sectors, including finance, government, telecommunications, healthcare, and e-commerce. Snorkel AI's innovative approach incorporates weak supervision technology, allowing both developers and non-developers to focus on data-related tasks efficiently. Founded in 2016 and headquartered in Palo Alto, California, Snorkel AI also contributes to the academic community by publishing peer-reviewed research on its core technologies.

FullStory

Series D in 2021
FullStory, Inc. is a company that specializes in customer experience analytics, offering a platform that captures and analyzes various customer interaction data. The platform provides features such as pixel-perfect session playback, automatic insights, and funnel analytics, enabling organizations to optimize their online customer experiences. FullStory serves a diverse range of professionals, including product managers, designers, developers, and support agents, by delivering valuable insights into user behavior and engagement. Founded in 2014 and headquartered in Atlanta, Georgia, FullStory was previously known as Monetology, LLC until its name change in 2015. The company has also established a strategic partnership with Digital Yalo to enhance its offerings.

Sonoma Biotherapeutics

Series B in 2021
Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.

Ahana

Series A in 2021
Ahana, founded in 2020 and located in San Mateo, California, specializes in PrestoDB-based ad hoc analytics solutions. As the first company to focus on bringing these offerings to market, Ahana aims to simplify ad hoc analytics for organizations of various sizes. The company's mission includes fostering growth and supporting the Presto community, which is already in extensive use by major internet companies. Ahana operates as a fully remote organization, reflecting its commitment to flexibility and modern workplace practices.

Neuralink

Series C in 2021
Neuralink Corp. is a neural technology company focused on developing brain-computer interfaces (BCIs) that facilitate direct communication between the human brain and computers. Founded in 2016 and headquartered in San Francisco, California, with an additional office in Burlingame, the company aims to create implants that can treat brain injuries and trauma. Neuralink's innovative approach includes a concept referred to as a "neural lace," which would be surgically integrated into the brain, enabling users to interact with computers without the limitations of traditional input methods like keyboards and mice. The company is also exploring the potential of brain interfaces to alleviate symptoms of serious and chronic medical conditions, striving to enhance cognitive capabilities and keep pace with advances in artificial intelligence.

Nym

Venture Round in 2021
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.

Norby

Seed Round in 2021
Norby is an audience relationship toolkit built for creators and brands.

TMRW Life Sciences

Series C in 2021
TMRW Life Sciences is a developer of a cryo-storage platform intended to improve the success rates of assisted reproductive technology. The company's platform offers an in-clinic robotic storage system and a fully digital chain of custody from clinic to offsite longterm storage, continuous remote and local monitoring and electronically integrated processes characterized by digital health signals received from every oocyte and embryo daily, enabling clients to streamline embryology lab operations, eliminate manual steps and integrates digital quality control.

Instawork

Series C in 2021
Instawork operates an online job marketplace designed to connect hospitality businesses with qualified workers. The platform automates the recruitment process, allowing businesses to fill job shifts on demand while enabling professionals to choose work that fits their schedules. By streamlining traditional recruiting methods, Instawork creates economic opportunities for both local businesses and workers. The company is rapidly expanding its reach across the United States, focusing on meeting the evolving needs of the hospitality sector.

Xilis

Series A in 2021
Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

Physna

Series B in 2021
Physna LLC is a software company based in Cincinnati, Ohio, founded in 2015. It specializes in developing a geometric search engine that enhances computer-aided design (CAD) and 3D printing processes. The platform utilizes proprietary algorithms and advanced geometric deep learning technology to transform 3D models into a structured data format, facilitating comparison and analysis for quality control and automated inspection. Physna's solutions are applicable across various industries, including manufacturing, aerospace, defense, and consumer goods, enabling clients to improve efficiency, reduce costs, and streamline inspection automation. The company's innovative approach effectively bridges the gap between physical objects and digital representations, contributing to advancements in design and manufacturing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.